insights_auto
Why is EDIT down 2.47%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.78
arrow_downward
-2.47%(-0.045) 1D
Nov 18, 3:19:45 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.86
High
$1.94
Low
$1.77
Mkt. cap
273.97M
Avg. vol.
2.39M
Volume
1.51M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.86
High
$1.94
Low
$1.77
Mkt. cap
273.97M
Avg. vol.
2.39M
Volume
1.51M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%
ChartMill
·
2 hours ago
S&P 500 Unusual Volume Movers: Nov. 18, 2026
BigGo Finance
·
1 hour ago
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
Traders Union
·
59 minutes ago
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com